Bispebjerg Hospital
Copenhagen, Denmark
NCT Number: NCT02651298
Fractional Co2-laser for treatment of mature caesarean section scars.
Looking for future studies?
Notify Me22 year–55 year
Female
Interventional
Not applicable
Copenhagen, Denmark
Randomized split scar study to document improvement of caesarean section scars as compared to untreated control scar.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
laser treatment
Other names: Ablative fractional laser
Time frame: up until 6 months post treatment
validated scar scale evaluations
Time frame: 1 months post treatment
measured by reflectance
Time frame: 1 months post treatment
measured by reflectance
Time frame: 3 months post treatment
measured by reflectance
Time frame: 3 months post treatment
measured by reflectance
Time frame: 6 months post treatment
measured by reflectance
Time frame: 6 months post treatment
measured by reflectance
Time frame: 3 months post treatment
Bispebjerg Hospital
Other
Fractional CO2-laser Treatment of Caesarean Section Scars - A Randomized Controlled Split-scar Trial With Long Term Follow-up Assessment
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07153393
Atrophic Scar, Cicatrix
Naples, Italy
View Trial DetailsNCT04824612
Cicatrix, Collagen Diseases
São Paulo, Brazil
View Trial DetailsNCT04066946
Cicatrix, Fibrosis
Antwerp, Belgium
View Trial DetailsNCT02985151
Carbon Dioxide Laser, Cicatrix
St Louis, Missouri, United States
View Trial Details